246 related articles for article (PubMed ID: 7160161)
1. Current status of oral agents in diabetes.
Kilo C
Compr Ther; 1982 Dec; 8(12):26-32. PubMed ID: 7160161
[No Abstract] [Full Text] [Related]
2. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
3. [Risks of peroral treatment of diabetes].
Rybka J
Vnitr Lek; 1983 Nov; 29(11):1114-8. PubMed ID: 6659388
[No Abstract] [Full Text] [Related]
4. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
5. [Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent)].
Rodríguez-Miñón JL; Herrera Pombo JL; Marrón JA
Rev Clin Esp; 1971 Dec; 123(5):439-42. PubMed ID: 5160567
[No Abstract] [Full Text] [Related]
6. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
7. When--and how--to use an oral agent.
Shuman CR
Med Times; 1980 May; 108(5):77-81, 85-6. PubMed ID: 7374409
[No Abstract] [Full Text] [Related]
8. Oral agents and the elderly diabetic.
Skillman TG
Geriatrics; 1979 Dec; 34(12):41-6. PubMed ID: 499816
[No Abstract] [Full Text] [Related]
9. [Oral antidiabetics].
Bäbler M
Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
[No Abstract] [Full Text] [Related]
10. [Pharmacology and therapeutics: oral antidiabetic agents - usage and current trends].
Beltrán Lendinez M; Parras Puche M; Liebanas Pegalajar C; García Jiménez JA
Rev Enferm; 1982 Feb; 5(44):13-8. PubMed ID: 7041228
[No Abstract] [Full Text] [Related]
11. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
Domingo Gutiérrez AJ; Fernández-Cruz A
Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
[No Abstract] [Full Text] [Related]
12. The oral hypoglycaemic agents reassess.
Drug Ther Bull; 1974 Mar; 12(5):17-20. PubMed ID: 4820614
[No Abstract] [Full Text] [Related]
13. Insulin Independent.
Tsai A
Diabetes Forecast; 2015; 68(3):24, 26, 29. PubMed ID: 26665809
[No Abstract] [Full Text] [Related]
14. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
Calvet JM; Matarrodona M; Bordas R
Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
[No Abstract] [Full Text] [Related]
15. [Oral antidiabetics 1977].
Berger W
ZFA (Stuttgart); 1978 Mar; 54(9):513-24. PubMed ID: 636543
[No Abstract] [Full Text] [Related]
16. [Indications and limitations of oral hypoglycemic agents in the treatment of diabetes mellitus].
Guillon J; Charbonnel B
Cah Med; 1972 Nov; 13(14):999-1006. PubMed ID: 4646244
[No Abstract] [Full Text] [Related]
17. [Experimental and clinical pharmacology of oral antidiabetics].
Cuomo V; Marino A
Clin Ter; 1972 Sep; 62(6):505-52. PubMed ID: 4674507
[No Abstract] [Full Text] [Related]
18. [Indication and method of administration of oral antidiabetic agents].
Tasaka Y
Nihon Rinsho; 1997 Nov; 55 Suppl():99-103. PubMed ID: 9434451
[No Abstract] [Full Text] [Related]
19. [Clinical trial of glypizide].
Cañadell Vidal J
Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
[No Abstract] [Full Text] [Related]
20. The use of oral hypoglycemic agents.
Kilo C
Hosp Pract; 1979 Mar; 14(3):103-10. PubMed ID: 468201
[No Abstract] [Full Text] [Related]
[Next] [New Search]